The Harlow site was acquired in December 2016 from GlaxoSmithKline and provides an opportunity create c. 525,000 sq ft of Logistics Space alongside an existing 61,000 sq ft GSK facility leased back to Mulberry.  Mulberry are currently in the process of obtaining outline planning for Connex Park whilst also marketing the site with a view to breaking ground in the spring of 2018.  For further information about the opportunity please visit www.connexpark.co.uk.

Development Details
Description Storage, Distributionand Data Centre Development Space with retained investment property
Site Area 44.6 Acres (27 acres developable)
Building Sizes 525,000 sq ft
Agent  JLL / M1
Status Planning application